Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2003
08/13/2003EP1333860A1 Antibodies to the propeptide of candida albicans and methods of use
08/13/2003EP1333859A2 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network
08/13/2003EP1333858A1 Vaccines with enhanced immune response and methods for their preparation
08/13/2003EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
08/13/2003EP1333856A1 Modulating angiogenesis
08/13/2003EP1333850A2 Method and composition for inhibition of tumor growth and enhancing an immune response
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333814A1 Parenterally administrable microparticles
08/13/2003EP1181025B1 Molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
08/13/2003EP1163008B1 Use of trehalose for stabilising a liquid vaccine
08/13/2003EP1152768B1 Treatment of chronic viral infections with m. vaccae
08/13/2003EP1112495B1 Disaccharide derivatives
08/13/2003EP1098665B9 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
08/13/2003EP0812213B1 Gel form of a vaccine
08/13/2003EP0789587B1 Combined meningitis vaccine
08/13/2003EP0669980B1 Method of controlling polypeptide production in bacteria
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436236A Gasci基因 Gasci gene
08/13/2003CN1436234A Composition and methods for therapy and diagnosis of prostate cancer
08/13/2003CN1435433A Long-acting broad-spectrum chemotactic factor receptor inhibiting matter
08/13/2003CN1435260A Yolk antirotavirus antibody preparation, method for preparing same and use thereof
08/13/2003CN1435259A Preparation and use of chronic hepatitis B therapeutic DNA vaccine
08/13/2003CN1117862C Live attenuated RTX-producing bacteria of family pasteurellaceae
08/13/2003CN1117763C Anti-alphaV-integrin monoclonal antibody
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/12/2003US6605711 NY-ESO-1 peptide derivatives, and uses thereof
08/12/2003US6605702 Protein for use in the treatment of inflammatory defects and asthma
08/12/2003US6605696 Vaccines for pig porcine proliferative enteropathy (PPE)
08/12/2003US6605592 Protein HOFNF53
08/12/2003US6605588 Amino acid sequence of SEQ ID NO:6
08/12/2003US6605467 Fusion protein comprising the whole or part of the PP65 protein of human CMV, useable in particular for preparing a vaccine
08/12/2003US6605465 Methods for avoiding maternal immunity
08/12/2003US6605464 Expressible polynucleotides encoding eukaryotic heat shock proteins
08/12/2003US6605460 Avian pneumovirus vaccine
08/12/2003US6605457 Influenza vaccine
08/12/2003US6605449 Saturation mutagenesis to produce progenitor polynucleotide library
08/12/2003US6605437 Screening methods for compounds useful for the treatment of body weight disorders, including obesity
08/12/2003US6605426 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
08/12/2003US6605287 Vaccines for Chlamydia psittaci infections
08/12/2003US6605286 Delivery of biologically active polypeptides
08/12/2003US6605285 Vaccine for protection of poultry against salmonellosis and a process for preparing the same
08/12/2003US6605284 Gene coding for the measles virus mutant antigen
08/12/2003US6605282 Inducing immune response against feline immunodeficiency virus; obtain animal, administer protective agent, detect immunological response against viral infection
08/12/2003US6605279 Nucleotide sequences coding preferential polypeptide for use in intensifying immunological response
08/12/2003US6605277 Conformation-specific anti-von Willebrand factor antibodies
08/12/2003US6605276 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms
08/12/2003CA2248653C Vaccines for treatment of lymphoma and leukemia
08/12/2003CA2216425C Tetanus toxin functional fragment antigen and tetanus vaccine
08/12/2003CA2116888C Human anti-tnf antibodies
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065042A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/07/2003WO2003065010A2 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064632A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
08/07/2003WO2003064622A2 Aggrecanase molecules
08/07/2003WO2003064616A2 Compounds and methods for inducing growth arrest and apoptosis
08/07/2003WO2003064612A2 Identification of mutant antigens with enhanced immunogenicity
08/07/2003WO2003064607A2 Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions
08/07/2003WO2003064606A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003WO2003064603A2 Nucleic acid molecule encoding iwu-1
08/07/2003WO2003064595A2 Recombinant herpesvirus of turkeys and use thereof
08/07/2003WO2003064475A1 Novel monoclonal antibody and nematode larval antigens
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064457A1 A method for inhibiting 'melanoma inhibitory activity' mia
08/07/2003WO2003064450A2 Epizootic catarrhal enteritis prevention, treatment and diagnosis
08/07/2003WO2003064446A2 Plasma protein-binding peptides from bacterial curli
08/07/2003WO2003063910A2 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER
08/07/2003WO2003063907A1 Drugs ameliorating circadian rhythum disorder
08/07/2003WO2003063906A1 Drugs for treating inflammatory diseases
08/07/2003WO2003063899A2 Vaccine adjuvant based on a cd4 0 ligand
08/07/2003WO2003063897A1 Method of providing prophylaxis for tuberculosis in hiv positive individuals
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063883A1 Mkrtachian embryonal antitumoral modulator, method for the production and use thereof
08/07/2003WO2003063802A2 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
08/07/2003WO2003063801A2 Treatment of tumor cells for use in immunotherapy of cancer
08/07/2003WO2003063799A2 Compositions and methods for systemic inhibition of cartilage degradation
08/07/2003WO2003063798A2 Compositions and methods for treatment of infectious and inflammatory diseases
08/07/2003WO2003063792A2 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003WO2003063786A2 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system
08/07/2003WO2003063785A2 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
08/07/2003WO2003063772A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063767A2 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003WO2003063766A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003WO2003063725A2 Methods of preventing and treating flavivirus infection in animals
08/07/2003WO2003040340A9 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003008640A3 Asthma-associated gene
08/07/2003WO2002094228A8 Prevention and treatment of allergies by helminthic regulation of ige
08/07/2003WO2002092825B1 Retroviral vectors for gene therapy
08/07/2003WO2002088334A9 Chimeric immunoreceptor useful in treating human cancers
08/07/2003WO2002083069A3 Recombinant proteins of orientia tsutsugamushi
08/07/2003WO2002072792A8 Heterologous fusion protein constructs comprising a leishmania antigen
1 ... 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 ... 1823